117 related articles for article (PubMed ID: 12356421)
1. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate.
Johansson F; Hjertberg E; Eirefelt S; Tronde A; Hultkvist Bengtsson U
Eur J Pharm Sci; 2002 Oct; 17(1-2):63-71. PubMed ID: 12356421
[TBL] [Abstract][Full Text] [Related]
2. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
Mukherjee T; Squillantea E; Gillespieb M; Shao J
Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
[TBL] [Abstract][Full Text] [Related]
3. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.
Degim Z; Unal N; Eşsiz D; Abbasoglu U
Life Sci; 2004 Oct; 75(23):2819-27. PubMed ID: 15464833
[TBL] [Abstract][Full Text] [Related]
4. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers.
Mukaizawa F; Taniguchi K; Miyake M; Ogawara K; Odomi M; Higaki K; Kimura T
Int J Pharm; 2009 Feb; 367(1-2):103-8. PubMed ID: 18929635
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium taurocholate on the absorption of inhaled 99mTc-DTPA.
Bondesson E; Bengtsson T; Nilsson LE; Wollmer P
Pharm Res; 2006 Sep; 23(9):2122-8. PubMed ID: 16902815
[TBL] [Abstract][Full Text] [Related]
6. Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?
Berginc K; Trontelj J; Kristl A
Int J Pharm; 2012 Jun; 429(1-2):22-30. PubMed ID: 22449411
[TBL] [Abstract][Full Text] [Related]
7. Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro.
Tirumalasetty PP; Eley JG
J Pharm Pharm Sci; 2006; 9(1):32-9. PubMed ID: 16849006
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of a novel oral insulin formulation.
Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
[TBL] [Abstract][Full Text] [Related]
9. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
10. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
11. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models.
Meaney C; O'Driscoll C
Eur J Pharm Sci; 1999 Jul; 8(3):167-75. PubMed ID: 10379039
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes.
Yano K; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
J Pharm Sci; 2010 Mar; 99(3):1336-45. PubMed ID: 19743502
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2).
Kamm W; Jonczyk A; Jung T; Luckenbach G; Raddatz P; Kissel T
Eur J Pharm Sci; 2000 May; 10(3):205-14. PubMed ID: 10767598
[TBL] [Abstract][Full Text] [Related]
14. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
15. Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2).
Werner U; Kissel T; Reers M
Pharm Res; 1996 Aug; 13(8):1219-27. PubMed ID: 8865316
[TBL] [Abstract][Full Text] [Related]
16. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
[TBL] [Abstract][Full Text] [Related]
18. A potential mechanism of a cationic cyclopeptide for enhancing insulin delivery across Caco-2 cell monolayers.
Chang M; Li X; Sun Y; Cheng F; Li Y; Zhao W; Wang Q
Biol Pharm Bull; 2013; 36(10):1602-7. PubMed ID: 23924822
[TBL] [Abstract][Full Text] [Related]
19. Effect of sinomenine on the in vitro intestinal epithelial transport of selected compounds.
Lu Z; Chen W; Viljoen A; Hamman JH
Phytother Res; 2010 Feb; 24(2):211-8. PubMed ID: 19585475
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers.
Cho SY; Kim JS; Li H; Shim C; Linhardt RJ; Kim YS
Arch Pharm Res; 2002 Feb; 25(1):86-92. PubMed ID: 11885699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]